Mar 2019 – TIMEBIO Co., Ltd. was founded

Apr 2019 – Established corporate research institute (Certified by Korea Industrial Technology Association)

Jul 2019 – Completed clean room construction and class validation

Nov 2019 – Research using human source granted IRB (Institutional Review Board) approval

Nov 2019 – Signed a 10-year supply contract (exclusive in South Korea) for ATO STANDARD with THERAGEN ETEX Co., Ltd.


Jan 2020 – Acquired permission for manufacturer and marketing authorization holder from KFDA

Mar 2020 – Acquired permission for LMO (Living Modified Organism) research facility from KCDC

Apr 2020 – Completed toxicity test for TEXsome (Own developed exosome)

May 2020 – Acquired VENTURE COMPANY certification by Ministry of SMEs and Startups

May 2020 – TEXsome acquired approval for INCI application and published in ICID

Jun 2020 – Attend 2020 BIO USA (BIO DIGITAL) (Supported by KOTRA)

Jun 2020 – Completed licensing for cell line establishment


Office 1201-1202, Ace Gwanggyo Tower 3rd, 77, No.256 road, Changryong-daero  Yeongtong-gu, Suwon, Gyeonggi-do, South Korea.

​주식회사 타임바이오

Tel : +82 31-211-3488



  • White Facebook Icon
  • White Instagram Icon